Related Experiment Videos

Carcinoid tumor regression with high-dose octreotide acetate: a patient report

¹The Cancer Center of Boston, Massachussetts 02120, USA.

American Journal of Clinical Oncology

|June 17, 1998

Abstract:

A patient who had carcinoid tumor of the ileum and liver and intraabdominal lymph-node metastases sustained a substantial (more than 50%) reduction of metastatic tumor burden when treated with accelerated-dosage octreotide.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials.

British journal of cancer·2004

Phase I clinical trial of weekly combined topotecan and irinotecan.

American journal of clinical oncology·2001

Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors.

Cancer·2001

Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluorouracil.

Cancer investigation·1999

Single-dose granulocyte colony-stimulating factor concomitant with multifractionated dose chemotherapy: a strategy for maintaining dose intensity.

Cancer investigation·1999

See all related articles